General Information
Drug ID
DR01212
Drug Name
Mitomycin
Synonyms
Ametycin; 1950/7/7; 7-Amino-9alpha-methoxymitosane; Ametycin; Ametycine; C15H18N4O5; CCRIS 414; EINECS 200-008-6; HSDB 3239; MMC; Mit-C; Mitamycin; Mito-C; Mitocin C; Mitocin-C; Mitomicina; Mitomicina [INN-Spanish]; Mitomycin (TN); Mitomycin (USP/INN); Mitomycin C; Mitomycin C (JP15); Mitomycin C from Streptomyces caespitosus; Mitomycin C,; Mitomycin C, Streptomyces caespitosus; Mitomycin C, Streptomyces caespitosus, Carrier-Free; Mitomycin [USAN:INN:BAN]; Mitomycin-C; Mitomycine; Mitomycine [INN-French]; Mitomycins; Mitomycinum; Mitomycinum C; Mitomycinum [INN-Latin]; Mitomycyna C; Mitomycyna C [Polish]; Mitosol; Mitozytrex; Muamycin; Muamycin (TN); Mutamycin; Mytomycin; Mytozytrex; NCI-C04706; NSC 26980; NSC-26980; NSC26980; RCRA waste number U010; UNII-50SG953SK6; mitomycin C
Drug Type
Small molecular drug
Indication Anxiety [ICD11: MB24.3] Approved [1]
Therapeutic Class
Anticancer Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5746"></iframe>
3D MOL 2D MOL
Formula
C15H18N4O5
Canonical SMILES
CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N
InChI
InChI=1S/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,13+,15-/m1/s1
InChIKey
NWIBSHFKIJFRCO-WUDYKRTCSA-N
CAS Number
CAS 50-07-7
Pharmaceutical Properties Molecular Weight 334.332 Topological Polar Surface Area 147
Heavy Atom Count 24 Rotatable Bond Count 4
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 8
XLogP
-0.4
PubChem CID
5746
PubChem SID
11120094 , 11120582 , 11121070 , 11121809 , 11122289 , 11147177 , 11363021 , 11365583 , 11368145 , 11371173 , 11371174 , 11373746 , 11376307 , 14899962 , 14924490 , 15249200 , 24896554 , 24896555 , 24896917 , 26759169 , 26759192 , 29224783 , 46508353 , 47440503 , 47440504 , 47589205 , 48414068 , 48416286 , 48423722 , 49854359 , 50064401 , 50111457 , 53787087 , 56310827 , 56311910 , 56312869 , 56312950 , 56313687 , 56313798 , 56313799 , 56314173 , 56314310 , 57260126 , 57322926 , 613813 , 7847275 , 8144500 , 8153525 , 87663 , 8906
ChEBI ID
ChEBI:27504
TTD Drug ID
D0Y0GH
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Mitomycin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 In vivo expansion of MDR1-transduced cells accompanied by a post-transplantation chemotherapy regimen with mitomycin C and methotrexate. J Gene Med. 2010 Jul;12(7):596-603.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.